Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
E-pub ahead of print

Novel approach for CES1 genotyping: integrating single nucleotide variants and structural variation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Reappraisal of the genetic diversity and pharmacogenetic assessment of CES1

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Rationale and design of the multiethnic Pharmacogenomics in Childhood Asthma consortium

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Pulmonary administration of remdesivir in the treatment of COVID-19

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The impact of human CES1 genetic variation on enzyme activity assessed by ritalinic acid/methylphenidate ratios

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

AIM: Development of a specific procedure for genotyping of CES1A1 (CES1) and CES1A2, a hybrid of CES1A1 and the pseudogene CES1P1.

MATERIALS & METHODS: The number of CES1A1 and CES1A2 copies and that of CES1P1 were determined using real-time PCR. Long range PCRs followed by secondary PCRs allowed sequencing of single nucleotide variants in CES1A1 and CES1A2. Results & conlusion: A procedure consisting of two main steps was developed. Its first main step, the copy number determination, informed about presence of CES1A2 . This information enabled choice of PCR in the second main step, which selectively amplified CES1A1 and, if present, also CES1A2, for subsequent sequencing. Examination of 501 DNA samples suggested that our procedure is specific with potential for personalization of drug treatments.

OriginalsprogEngelsk
TidsskriftPharmacogenomics
ISSN1462-2416
DOI
StatusE-pub ahead of print - 19 feb. 2018

ID: 52796485